Efficacy and safety of tacrolimus in patients with rheumatoid arthritis – A systematic review and meta-analysis

Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan

(2017) Tsutomu Takeuchi et al.   Modern Rheumatology

Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial

(2014) Shinichi Kawai et al.   Modern Rheumatology

Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study

(2014) Yoshiya Tanaka et al.   Modern Rheumatology

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

(2010) YH Lee et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis

(2009) Katsuya Suzuki et al.   RHEUMATOLOGY INTERNATIONAL